StockData

Can B Corp (NASC) stock

NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)

Close on Oct 19, 2026Market cap $981.54KP/E –Yield –

Can B EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Can B's EPS for the twelve months ending Sep 30, 2023 was -$1.79. For fiscal 2023 it was -$0.77. The highest annual figure on record is $0.00 in fiscal 2016.

Annual eps

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$0.77–
FY2022Dec 31, 2022-$4.18–
FY2021Dec 31, 2021-$9.06–
FY2020Dec 31, 2020-$37.68–
FY2019Dec 31, 2019-$33.00–
FY2018Dec 31, 2018-$45.00–
FY2017Dec 31, 2017$0.00–
FY2016Dec 31, 2016$0.00–
FY2015Dec 31, 2015-$90.00–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024-$0.05–
Q2 FY2024Jun 30, 2024-$0.04–
Q1 FY2024Mar 31, 2024-$0.16–
Q3 FY2023Sep 30, 2023-$0.36–
Q2 FY2023Jun 30, 2023-$0.37–
Q1 FY2023Mar 31, 2023-$0.36–
Q4 FY2022Dec 31, 2022-$0.70–
Q3 FY2022Sep 30, 2022-$1.98–
Q2 FY2022Jun 30, 2022-$0.49–
Q1 FY2022Mar 31, 2022-$1.10–
Q3 FY2021Sep 30, 2021-$1.65–
Q2 FY2021Jun 30, 2021-$1.80–
Q1 FY2021Mar 31, 2021-$3.60–
Q4 FY2020Dec 31, 2020-$16.29–
Q3 FY2020Sep 30, 2020-$5.55–
Q2 FY2020Jun 30, 2020-$4.95–
Q1 FY2020Mar 31, 2020-$4.95–
Q4 FY2019Dec 31, 2019-$13.68–
Q3 FY2019Sep 30, 2019-$4.80–
Q2 FY2019Jun 30, 2019-$9.00–
Q1 FY2019Mar 31, 2019$0.00–
Q3 FY2018Sep 30, 2018$0.00–
Q2 FY2018Jun 30, 2018$0.00–
Q1 FY2018Mar 31, 2018$0.00–
Q3 FY2017Sep 30, 2017$0.00–
Q2 FY2017Jun 30, 2017$0.00–
Q1 FY2017Mar 31, 2017$0.00–
Q3 FY2016Sep 30, 2016$0.00–
Q2 FY2016Jun 30, 2016$0.00–
Q1 FY2016Mar 31, 2016$0.00–
Q4 FY2015Dec 31, 2015-$4.16–
Q3 FY2015Sep 30, 2015$0.00–
Q2 FY2015Jun 30, 2015$0.00–

More Can B figures

See a number that looks wrong?